Get the Stockscreener App
0.596
2.76%
0.016
After Hours:
.59
-0.006
-1.01%
Virax Biolabs Group Ltd stock is traded at $0.596, with a volume of 41,073.
It is up +2.76% in the last 24 hours and down -23.17% over the past month.
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
See More
Previous Close:
$0.58
Open:
$0.5702
24h Volume:
41,073
Relative Volume:
0.08
Market Cap:
$2.59M
Revenue:
$79,300
Net Income/Loss:
$-6.92M
P/E Ratio:
-0.0314
EPS:
-18.9818
Net Cash Flow:
$-5.34M
1W Performance:
+5.49%
1M Performance:
-23.17%
6M Performance:
-59.50%
1Y Performance:
-77.34%
1-Day Range:
$0.5702
$0.5969
1-Week Range:
$0.5296
$0.5969
52-Week Range:
$0.5202
$3.62
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Name
Virax Biolabs Group Ltd
Sector
Industry
Phone
-
Address
-
Compare VRAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.596 | 2.52M | 79,300 | -6.92M | -5.34M | -18.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Stock (VRAX) Latest News
how moving averages guide virax biolabs group limited trading2025 Market WrapUp & Stepwise Trade Signal Guides - Newser
Is it time to cut losses on Virax Biolabs Group LimitedJuly 2025 Action & Risk Controlled Stock Alerts - Newser
Is a relief rally coming for Virax Biolabs Group Limited holdersJuly 2025 Rallies & Low Drawdown Momentum Ideas - Newser
Is Virax Biolabs Group Limited still worth holding after the dip2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - Newser
How moving averages guide Virax Biolabs Group Limited tradingWeekly Investment Report & Verified Entry Point Signals - Newser
Forecasting Virax Biolabs Group Limited price range with options dataJuly 2025 Volume & Daily Entry Point Alerts - Newser
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update - Defense World
What machine learning models say about Virax Biolabs Group LimitedM&A Rumor & Low Risk Entry Point Tips - Newser
Tools to assess Virax Biolabs Group Limited’s risk profileGold Moves & Free Safe Capital Growth Stock Tips - Newser
Multi factor analysis applied to Virax Biolabs Group LimitedDividend Hike & Daily Chart Pattern Signal Reports - Newser
Risk vs reward if holding onto Virax Biolabs Group LimitedWeekly Profit Analysis & Reliable Volume Spike Trade Alerts - Newser
Is Virax Biolabs Group Limited meeting your algorithmic filter criteriaMarket Volume Summary & Safe Capital Growth Tips - Newser
Is Virax Biolabs Group Limited stock entering bullish territoryCPI Data & Proven Capital Preservation Methods - Newser
Can technical indicators confirm Virax Biolabs Group Limited’s reversalQuarterly Portfolio Report & Fast Momentum Entry Tips - Newser
What’s next for Virax Biolabs Group Limited stock priceJuly 2025 Snapshot & Safe Capital Allocation Plans - Newser
Does Virax Biolabs Group Limited align with a passive investing strategy - خودرو بانک
Virax Biolabs Group Limited Recovery Likely Here’s What Data ShowsJuly 2025 PreEarnings & AI Based Trade Execution Alerts - beatles.ru
Market reaction to Virax Biolabs Group Limited’s recent newsJuly 2025 Movers & Low Drawdown Momentum Ideas - Newser
Combining price and volume data for Virax Biolabs Group Limited2025 Price Action Summary & Fast Entry Momentum Alerts - Newser
What recovery options are there for Virax Biolabs Group Limited2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
Can volume confirm reversal in Virax Biolabs Group LimitedWeekly Trade Report & AI Powered Buy/Sell Recommendations - Newser
Statistical indicators supporting Virax Biolabs Group Limited’s strengthQuarterly Profit Review & Daily Oversold Bounce Ideas - Newser
Virax Biolabs Group Limited stock trend forecastSell Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Is Virax Biolabs Group Limited’s ROE strong enoughProfit Target & Technical Confirmation Trade Alerts - خودرو بانک
Can trapped investors hope for a rebound in Virax Biolabs Group LimitedJuly 2025 Institutional & Accurate Technical Buy Alerts - Newser
Volatility clustering patterns for Virax Biolabs Group LimitedJuly 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Will Virax Biolabs Group Limited benefit from geopolitical trendsWeekly Gains Summary & Daily Momentum Trading Reports - خودرو بانک
Can Virax Biolabs Group Limited hit a new high this monthMarket Weekly Review & Daily Stock Trend Watchlist - Newser
Has Jewett Cameron Trading Company Ltd. found a price floor2025 Technical Patterns & Fast Entry High Yield Tips - Newser
What Technical Tools Say About Virax Biolabs Group Limited Recovery getLinesFromResByArray error: size == 0 - thegnnews.com
Best data tools to analyze Castor Maritime Inc. stockQuarterly Profit Review & Stock Portfolio Risk Control - Newser
What Fibonacci levels say about The Hartford Insurance Group Inc. reboundJuly 2025 Chart Watch & Daily Profit Maximizing Trade Tips - Newser
Will Torrid Holdings Inc. rebound enough to break even2025 Price Targets & AI Forecast Swing Trade Picks - Newser
Is Virax Biolabs Group Limited on track to beat earningsTrade Exit Report & AI Optimized Trade Strategies - خودرو بانک
How moving averages guide PGYWW tradingWeekly Trade Review & Capital Efficient Trading Techniques - Newser
Real time scanner hits for Virax Biolabs Group Limited explainedGap Down & Weekly High Potential Alerts - Newser
Can a trend reversal in Virax Biolabs Group Limited lead to recovery2025 Top Gainers & Verified Entry Point Signals - Newser
Philip Morris International Inc. stock trend outlook and recovery path2025 Biggest Moves & Precise Buy Zone Identification - Newser
Adeia Inc. stock daily chart insightsEarnings Beat & Weekly High Potential Stock Alerts - Newser
Is it too late to sell ZIM Integrated Shipping Services Ltd.Swing Trade & Community Consensus Picks - Newser
Using data tools to time your MBOT exitWeekly Market Report & Risk Controlled Swing Alerts - Newser
Is ECARX Holdings Inc. a candidate for recovery play2025 Year in Review & Fast Gain Stock Trading Tips - Newser
Live market analysis of The Ensign Group Inc.Portfolio Return Report & Fast Momentum Stock Entry Tips - Newser
How to track smart money flows in Essent Group Ltd.Trade Analysis Summary & Free Fast Gain Swing Trade Alerts - Newser
Has ATLX formed a bullish divergenceJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - Newser
Predicting Cycurion Inc. trend using moving averagesJuly 2025 Gainers & Comprehensive Market Scan Reports - Newser
What recovery options are there for TOP Financial Group LimitedNew Guidance & AI Driven Stock Movement Reports - Newser
Using RSI to spot recovery in Fossil Group Inc.Weekly Volume Report & Entry and Exit Point Strategies - Newser
Virax Biolabs Group Ltd Stock (VRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):